These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 18983856

  • 1. Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats.
    Wang F, Li M, Cheng L, Zhang T, Hu J, Cao M, Zhao J, Guo R, Gao L, Zhang X.
    Life Sci; 2008 Dec 19; 83(25-26):828-35. PubMed ID: 18983856
    [Abstract] [Full Text] [Related]

  • 2. Cilostazol protects diabetic rats from vascular inflammation via nuclear factor-kappa B-dependent down-regulation of vascular cell adhesion molecule-1 expression.
    Gao L, Wang F, Wang B, Gong B, Zhang J, Zhang X, Zhao J.
    J Pharmacol Exp Ther; 2006 Jul 19; 318(1):53-8. PubMed ID: 16595735
    [Abstract] [Full Text] [Related]

  • 3. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.
    Tone A, Shikata K, Sasaki M, Ohga S, Yozai K, Nishishita S, Usui H, Nagase R, Ogawa D, Okada S, Shikata Y, Wada J, Makino H.
    Diabetologia; 2005 Nov 19; 48(11):2402-11. PubMed ID: 16231067
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy.
    Li JJ, Lee SH, Kim DK, Jin R, Jung DS, Kwak SJ, Kim SH, Han SH, Lee JE, Moon SJ, Ryu DR, Yoo TH, Han DS, Kang SW.
    Am J Physiol Renal Physiol; 2009 Jul 19; 297(1):F200-9. PubMed ID: 19369290
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
    Xie X, Chang X, Chen L, Huang K, Huang J, Wang S, Shen X, Liu P, Huang H.
    Mol Cell Endocrinol; 2013 Dec 05; 381(1-2):56-65. PubMed ID: 23896433
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.
    Wu YG, Lin H, Qi XM, Wu GZ, Qian H, Zhao M, Shen JJ, Lin ST.
    Int Immunopharmacol; 2006 Mar 05; 6(3):445-53. PubMed ID: 16428080
    [Abstract] [Full Text] [Related]

  • 10. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.
    Zhang H, Yang Y, Wang Y, Wang B, Li R.
    Drug Des Devel Ther; 2018 Mar 05; 12():89-98. PubMed ID: 29386886
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
    Wang JJ, Zhang SX, Mott R, Chen Y, Knapp RR, Cao W, Ma JX.
    Am J Physiol Renal Physiol; 2008 May 05; 294(5):F1166-73. PubMed ID: 18322021
    [Abstract] [Full Text] [Related]

  • 13. Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways.
    Hu X, Zhang X, Jin G, Shi Z, Sun W, Chen F.
    Fundam Clin Pharmacol; 2017 Feb 05; 31(1):54-63. PubMed ID: 27521287
    [Abstract] [Full Text] [Related]

  • 14. Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats.
    Deepa B, Venkatraman Anuradha C.
    Toxicol Mech Methods; 2013 May 05; 23(4):223-34. PubMed ID: 23193997
    [Abstract] [Full Text] [Related]

  • 15. Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes.
    Suzuki K, Uchida K, Nakanishi N, Hattori Y.
    Am J Hypertens; 2008 Apr 05; 21(4):451-7. PubMed ID: 18369362
    [Abstract] [Full Text] [Related]

  • 16. Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Han SY, Kim CH, Kim HS, Jee YH, Song HK, Lee MH, Han KH, Kim HK, Kang YS, Han JY, Kim YS, Cha DR.
    J Am Soc Nephrol; 2006 May 05; 17(5):1362-72. PubMed ID: 16571782
    [Abstract] [Full Text] [Related]

  • 17. Cilostazol Attenuates Retinal Oxidative Stress and Inflammation in a Streptozotocin-Induced Diabetic Animal Model.
    Yeh PT, Huang YH, Chang SW, Wang LC, Yang CM, Yang WS, Lin CW, Yang CH.
    Curr Eye Res; 2019 Mar 05; 44(3):294-302. PubMed ID: 30373407
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
    Aoki M, Morishita R, Hayashi S, Jo N, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T.
    Diabetologia; 2001 Aug 05; 44(8):1034-42. PubMed ID: 11484082
    [Abstract] [Full Text] [Related]

  • 19. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes.
    Lee S, Kim W, Moon SO, Sung MJ, Kim DH, Kang KP, Jang KY, Lee SY, Park BH, Koh GY, Park SK.
    Nephrol Dial Transplant; 2007 Feb 05; 22(2):396-408. PubMed ID: 17085463
    [Abstract] [Full Text] [Related]

  • 20. Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-Beta and NF-kappaB.
    Lee WC, Chen HC, Wang CY, Lin PY, Ou TT, Chen CC, Wen MC, Wang J, Lee HJ.
    Biosci Biotechnol Biochem; 2010 Feb 05; 74(7):1355-61. PubMed ID: 20622454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.